Suppr超能文献

磷蛋白的四聚化对于呼吸道合胞病毒出芽至关重要,而其N端区域介导与基质蛋白的直接相互作用。

Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

作者信息

Bajorek Monika, Galloux Marie, Richard Charles-Adrien, Szekely Or, Rosenzweig Rina, Sizun Christina, Eleouet Jean-Francois

机构信息

Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.

Department of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.02217-20. Epub 2021 Jan 6.

Abstract

It was shown previously that the Matrix (M), Phosphoprotein (P), and the Fusion (F) proteins of Respiratory syncytial virus (RSV) are sufficient to produce virus-like particles (VLPs) that resemble the RSV infection-induced virions. However, the exact mechanism and interactions among the three proteins are not known. This work examines the interaction between P and M during RSV assembly and budding. We show that M interacts with P in the absence of other viral proteins in cells using a Split Nano Luciferase assay. By using recombinant proteins, we demonstrate a direct interaction between M and P. By using Nuclear Magnetic Resonance (NMR) we identify three novel M interaction sites on P, namely site I in the α region, site II in the 115-125 region, and the oligomerization domain (OD). We show that the OD, and likely the tetrameric structural organization of P, is required for virus-like filament formation and VLP release. Although sites I and II are not required for VLP formation, they appear to modulate P levels in RSV VLPs. Human RSV is the commonest cause of infantile bronchiolitis in the developed world and of childhood deaths in resource-poor settings. It is a major unmet target for vaccines and anti-viral drugs. The lack of knowledge of RSV budding mechanism presents a continuing challenge for VLP production for vaccine purpose. We show that direct interaction between P and M modulates RSV VLP budding. This further emphasizes P as a central regulator of RSV life cycle, as an essential actor for transcription and replication early during infection and as a mediator for assembly and budding in the later stages for virus production.

摘要

先前的研究表明,呼吸道合胞病毒(RSV)的基质(M)蛋白、磷蛋白(P)和融合(F)蛋白足以产生类似于RSV感染诱导的病毒粒子的病毒样颗粒(VLP)。然而,这三种蛋白之间的确切机制和相互作用尚不清楚。这项工作研究了RSV组装和出芽过程中P和M之间的相互作用。我们使用分裂纳米荧光素酶测定法表明,在细胞中不存在其他病毒蛋白的情况下,M与P相互作用。通过使用重组蛋白,我们证明了M和P之间存在直接相互作用。通过核磁共振(NMR),我们在P上鉴定出三个新的M相互作用位点,即α区域的位点I、115-125区域的位点II和寡聚化结构域(OD)。我们表明,OD以及可能的P的四聚体结构组织是病毒样丝状结构形成和VLP释放所必需的。尽管位点I和位点II不是VLP形成所必需的,但它们似乎调节RSV VLP中的P水平。人RSV是发达国家婴儿细支气管炎的最常见病因,也是资源匮乏地区儿童死亡的主要原因。它是疫苗和抗病毒药物的一个主要未满足的靶点。对RSV出芽机制缺乏了解,给用于疫苗目的的VLP生产带来了持续的挑战。我们表明,P和M之间的直接相互作用调节RSV VLP出芽。这进一步强调了P作为RSV生命周期的核心调节因子,作为感染早期转录和复制的重要参与者,以及作为后期病毒产生的组装和出芽的介质。

相似文献

3
Dimerization of matrix protein is required for budding of respiratory syncytial virus.
J Virol. 2015 Apr;89(8):4624-35. doi: 10.1128/JVI.03500-14. Epub 2015 Feb 11.
5
Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.
J Virol. 2014 Sep 1;88(17):10165-76. doi: 10.1128/JVI.01250-14. Epub 2014 Jun 25.
8
Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
Antiviral Res. 2014 Nov;111:129-35. doi: 10.1016/j.antiviral.2014.09.005. Epub 2014 Sep 18.
9

引用本文的文献

1
Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.
FASEB J. 2025 Jul 31;39(14):e70858. doi: 10.1096/fj.202500509RR.
2
Clinical Insights and Advancements in Human Metapneumovirus Management and Prognosis.
Discoveries (Craiova). 2025 Mar 31;13(1):e204. doi: 10.15190/d.2025.3. eCollection 2025 Jan-Mar.
3
Regulation of respiratory syncytial virus nucleoprotein oligomerization by phosphorylation.
J Biol Chem. 2025 Mar;301(3):108256. doi: 10.1016/j.jbc.2025.108256. Epub 2025 Feb 3.
4
Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein.
PLoS Pathog. 2024 Nov 19;20(11):e1012687. doi: 10.1371/journal.ppat.1012687. eCollection 2024 Nov.
7
Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice.
Infect Drug Resist. 2023 Sep 11;16:6099-6110. doi: 10.2147/IDR.S426039. eCollection 2023.
8
Respiratory syncytial virus ribonucleoproteins hijack microtubule Rab11 dependent transport for intracellular trafficking.
PLoS Pathog. 2022 Jul 7;18(7):e1010619. doi: 10.1371/journal.ppat.1010619. eCollection 2022 Jul.

本文引用的文献

1
Polymerase-tagged respiratory syncytial virus reveals a dynamic rearrangement of the ribonucleocapsid complex during infection.
PLoS Pathog. 2020 Oct 8;16(10):e1008987. doi: 10.1371/journal.ppat.1008987. eCollection 2020 Oct.
3
Cryo-EM structure of the respiratory syncytial virus RNA polymerase.
Nat Commun. 2020 Jan 17;11(1):368. doi: 10.1038/s41467-019-14246-3.
4
Structure of the human metapneumovirus polymerase phosphoprotein complex.
Nature. 2020 Jan;577(7789):275-279. doi: 10.1038/s41586-019-1759-1. Epub 2019 Nov 7.
5
Structure of the Respiratory Syncytial Virus Polymerase Complex.
Cell. 2019 Sep 19;179(1):193-204.e14. doi: 10.1016/j.cell.2019.08.014. Epub 2019 Sep 5.
7
Identification of a human respiratory syncytial virus phosphoprotein domain required for virus-like-particle formation.
Virology. 2019 Jun;532:48-54. doi: 10.1016/j.virol.2019.04.001. Epub 2019 Apr 9.
10
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
Lancet Infect Dis. 2018 Oct;18(10):e295-e311. doi: 10.1016/S1473-3099(18)30292-5. Epub 2018 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验